8-K/A XBRL

AMENDMENT TO FORM 8-K

Company: Tonix Pharmaceuticals Holding Corp.
Filed: December 3, 2024
Period of Report: December 3, 2024
Accession Number: 0001839882-24-043326

View Document ↗ View on SEC.gov ↗